<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Oren, Ohad</style></author><author><style face="normal" font="default" size="100%">Singh, Abhay</style></author><author><style face="normal" font="default" size="100%">Carraway, Hetty E.</style></author><author><style face="normal" font="default" size="100%">Laffin, Luke J.</style></author><author><style face="normal" font="default" size="100%">Nissen, Steven E.</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know</style></title><secondary-title><style face="normal" font="default" size="100%">Cleveland Clinic Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">289-295</style></pages><doi><style  face="normal" font="default" size="100%">10.3949/ccjm.93a.26003</style></doi><volume><style face="normal" font="default" size="100%">93</style></volume><issue><style face="normal" font="default" size="100%">5</style></issue><abstract><style  face="normal" font="default" size="100%">Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition defined by somatic mutations in hematopoietic stem cells that result in clonal expansion, without overt hematologic malignancy. It is now recognized as a potent risk factor for atherosclerotic cardiovascular disease, with emerging associations across a broader spectrum of cardiovascular phenotypes, including myocarditis, pericarditis, arrhythmias, valvular heart disease, and heart failure. The authors of this article review the epidemiology, pathophysiology, and management of this condition.</style></abstract></record></records></xml>